ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank50
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P50
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202520.21+135.0%
2024-57.66-209.1%
202352.86+487.0%
2022-13.66-0.2%
2021-13.62+11.6%
2020-15.41-112.9%
2019119.83+253.2%
201833.93+104.9%
2017-691.64-492.2%
2016176.36-